LeMaitre Vascular Inc (LMAT)
105.87
+2.43
(+2.35%)
USD |
NASDAQ |
Nov 21, 16:00
106.04
+0.18
(+0.17%)
After-Hours: 20:00
LeMaitre Vascular Enterprise Value: 2.256B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.256B |
| November 20, 2024 | 2.202B |
| November 19, 2024 | 2.209B |
| November 18, 2024 | 2.204B |
| November 15, 2024 | 2.170B |
| November 14, 2024 | 2.159B |
| November 13, 2024 | 2.182B |
| November 12, 2024 | 2.198B |
| November 11, 2024 | 2.248B |
| November 08, 2024 | 2.220B |
| November 07, 2024 | 2.149B |
| November 06, 2024 | 2.163B |
| November 05, 2024 | 2.094B |
| November 04, 2024 | 2.042B |
| November 01, 2024 | 2.009B |
| October 31, 2024 | 1.863B |
| October 30, 2024 | 1.878B |
| October 29, 2024 | 1.909B |
| October 28, 2024 | 1.839B |
| October 25, 2024 | 1.802B |
| October 24, 2024 | 1.823B |
| October 23, 2024 | 1.831B |
| October 22, 2024 | 1.838B |
| October 21, 2024 | 1.869B |
| October 18, 2024 | 1.897B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.893B |
| October 16, 2024 | 1.934B |
| October 15, 2024 | 1.927B |
| October 14, 2024 | 1.948B |
| October 11, 2024 | 1.913B |
| October 10, 2024 | 1.883B |
| October 09, 2024 | 1.965B |
| October 08, 2024 | 1.908B |
| October 07, 2024 | 1.888B |
| October 04, 2024 | 1.936B |
| October 03, 2024 | 1.917B |
| October 02, 2024 | 1.922B |
| October 01, 2024 | 1.919B |
| September 30, 2024 | 1.965B |
| September 27, 2024 | 1.948B |
| September 26, 2024 | 1.916B |
| September 25, 2024 | 1.892B |
| September 24, 2024 | 1.934B |
| September 23, 2024 | 1.941B |
| September 20, 2024 | 1.908B |
| September 19, 2024 | 1.913B |
| September 18, 2024 | 1.883B |
| September 17, 2024 | 1.883B |
| September 16, 2024 | 1.909B |
| September 13, 2024 | 1.902B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
391.67M
Minimum
Mar 23 2020
2.256B
Maximum
Nov 21 2024
1.066B
Average
1.017B
Median
Feb 15 2023
Enterprise Value Benchmarks
| Baxter International Inc | 28.43B |
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 11.14M |
| Revenue (Quarterly) | 54.82M |
| Total Expenses (Quarterly) | 41.67M |
| EPS Diluted (Quarterly) | 0.49 |
| Gross Profit Margin (Quarterly) | 67.82% |
| Profit Margin (Quarterly) | 20.32% |
| Earnings Yield | 1.73% |
| Operating Earnings Yield | 2.07% |
| Normalized Earnings Yield | 1.712 |